Reflections on durable therapies for diabetic macular edema amid COVID-19 pandemic
![Courtesy of Ophthalmology Times, Durable therapies for diabetic macular edema amid COVID-19 pandemic.](https://media.heidelbergengineering.com/_thumbnails/500x279/uploads/News/2021/12/20211220_diabetic_macular_edema.jpg)
An article in Ophthalmology Times by Dr. Caesar Luo overviews considerations for sustainable DME management options during the everchanging COVID-19 healthcare landscape, with an emphasis on the backlog caused by patients’ reluctance to visit clinics during the pandemic. It includes an interesting case study imaged using a SPECTRALIS OCT.